News | Blood Testing | October 26, 2018

Abbott Point-of-Care Blood Test Speeds Heart Attack Diagnosis

Bedside diagnostic test in development can rule out heart attack in as little as 15 minutes with similar accuracy to high-sensitive troponin test

Abbott Point-of-Care Blood Test Speeds Heart Attack Diagnosis

October 26, 2018 β€” For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a heart attack. New data, published online in JAMA Cardiology, found a new blood test under development that is done right at the patient's side in as little as 15 minutes could identify nearly three-fifths (56.7 percent) of people at low risk of experiencing a heart attack. The results are similar to the results of a High Sensitive Troponin-I blood test done in the laboratory setting.1

More than 7 billion diagnostic tests are run in the U.S. each year to help physicians make accurate, timely decisions about a person's medical treatment.2 Point-of-care diagnostic tests, that can often provide results within minutes, are used globally as hospitals face increased pressures to address overcrowding in emergency rooms and longer wait times. The goal of with-patient diagnostic tests is to deliver results with accuracy similar to the gold standard of high-sensitivity lab tests. The findings from the study indicate this new point-of-care blood test could help physicians streamline how patients are triaged in the emergency room by reducing the time it takes to rule out a heart attack and accelerating a safe discharge for low-risk patients – all with an accuracy comparable to a high sensitive cardiac troponin test used in a core-laboratory.

"The initial findings from this study indicate that, for a substantial proportion of patients, it may be possible to safely rule out heart attacks within 15 minutes of blood drawn in the emergency department," said Martin Than, M.D., an emergency medicine specialist, director of emergency medicine research at Christchurch Public Health Hospital and one of the study's senior authors. "This is a major advancement in point-of-care test accuracy that may make possible significant improvements in patient care in both urban and rural settings."

Researchers in New Zealand evaluated 354 adults 18 years and older who entered an emergency department with symptoms of acute coronary syndrome, such as a heart attack. The patients' cardiac troponin levels, which have become the standard for aiding doctors in checking for a heart attack, were measured using two Abbott blood tests: the Architect High Sensitive Troponin-I (hsTnI) and the i-STAT TnI-Nx, a point-of-care diagnostic test under development. The study found:

Similar levels of accuracy between the two tests (area under the curve: 0.975 and 0.970 for the i-STAT TnI-Nx and hsTnI tests respectively); and

Similar abilities to rule out a heart attack using the Emergency Department Assessment of Chest Pain Score: 56.7 percent of patients were identified as low risk using i-STAT TnI-Nx, compared to 43.5 percent of patients using hsTnI test.

Troponin proteins are released from the heart and can be found at elevated levels in the blood when the heart muscle has been damaged due to lack of blood flow. The i-STAT cardiac troponin test from Abbott has been used in hospitals globally to help aid the physician in diagnosing heart attacks, right at the patient's bedside. Abbott's newest point-of-care test, that was used in the research and is not yet commercially available, includes several enhancements, such as magnetic technology.

This analysis, published online Oct. 17, is part of a prospective observational study. The study's primary outcome was the area under receiver-operator-characteristic curve (AUC) and sensitivity, negative predictive value (NPV) and proportion negative at thresholds with 100 percent sensitivity. A total of 354 participants aged 18 years old and older with signs of acute coronary syndrome, including a heart attack, were enrolled between July 5, 2016 and Jan. 5, 2018. The investigator-led study was supported by a research grant from Abbott which did not participate in the planning or conduct of the data analysis.

For more information: www.pointofcare.abbott.com

Β 

References

  1. Pickering, J.W. et al. JAMA Cardiol. 2018; doi:10.1001/jamacardio.2018.3368
  2. American Clinical Laboratory Association. Value of Lab Testing. Retrieved from: https://www.acla.com/value-of-lab-testing/

Related Content

Technology | Blood Testing

October 9, 2019 β€” Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received ...

Home October 09, 2019
Home
News | Blood Testing

September 18, 2019 β€” Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high ...

Home September 18, 2019
Home
News | Blood Testing

March 19, 2019 β€” Prevencio Inc. announced data confirming the high accuracy of its artificial intelligence (AI)-driven ...

Home March 19, 2019
Home
News | Blood Testing

December 28, 2018 β€”Terrific Care LLC. / Medex Supply Dist Inc. initiated a nationwide recall on Dec. 19 of Roche ...

Home December 28, 2018
Home
News | Blood Testing

October 24, 2018 β€” For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes ...

Home October 24, 2018
Home
News | Blood Testing

October 16, 2018 β€” Abbott announced that its High Sensitive Troponin-I blood test has received CE Mark for distribution ...

Home October 16, 2018
Home
News | Blood Testing

September 4, 2018 β€” Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral ...

Home September 04, 2018
Home
News | Blood Testing

August 6, 2018 β€” A new test to assess a whether or not someone is having a heart attack upon arriving in the emergency ...

Home August 06, 2018
Home
News | Blood Testing

March 26, 2018 β€” Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singulex ...

Home March 26, 2018
Home
News | Blood Testing

September 7, 2017 β€” In July, The Heart Institute at Florida Medical Center became the first hospital in the state of ...

Home September 07, 2017
Home
Subscribe Now